Combined effects of cafeteria and tube-feeding on energy balance in the rat.

N. Rothwell,M. Stock

DOI: https://doi.org/10.1079/PNS19790026

1979-05-01

Proceedings of The Nutrition Society

Abstract:

What problem does this paper attempt to address?

Engineered exosomes: desirable target-tracking characteristics for cerebrovascular and neurodegenerative disease therapies

Meng Xu,Tao Feng,Bowen Liu,Fen Qiu,Youhua Xu,Yonghua Zhao,Ying Zheng

DOI: https://doi.org/10.7150/thno.62330

IF: 11.6

2021-01-01

Theranostics

Abstract:As extracellular vesicles secreted by cells, exosomes are intercellular signalosomes for cell communication and pharmacological effectors. Because of their special properties, including low toxicity and immunogenicity, biodegradability, ability to encapsulate endogenous biologically active molecules and cross the blood-brain barrier (BBB), exosomes have great therapeutic potential in cerebrovascular and neurodegenerative diseases. However, the poor targeting ability of natural exosomes greatly reduces the therapeutic effect. Using engineering technology, exosomes can obtain active targeting ability to accumulate in specific cell types and tissues by attaching targeting units to the membrane surface or loading them into cavities. In this review, we outline the improved targeting functions of bioengineered exosomes, tracing and imaging techniques, administration methods, internalization in the BBB, and therapeutic effects of exosomes in cerebrovascular and neurodegenerative diseases and further evaluate the clinical opportunities and challenges in this research field.

medicine, research & experimental
Native and Bioengineered Exosomes for Ischemic Stroke Therapy

Haroon Khan,Jia-Ji Pan,Yongfang Li,Zhijun Zhang,Guo-Yuan Yang

DOI: https://doi.org/10.3389/fcell.2021.619565

IF: 5.5

2021-03-23

Frontiers in Cell and Developmental Biology

Abstract:Exosomes are natural cells-derived vesicles, which are at the forefront toward clinical success for various diseases, including cerebral ischemia. Exosomes mediate cell-to-cell communication in different brain cells during both physiological and pathological conditions. Exosomes are an extensively studied type of extracellular vesicle, which are considered to be the best alternative for stem cell–based therapy. They can be secreted by various cell types and have unique biological properties. Even though native exosomes have potential for ischemic stroke therapy, some undesirable features prevent their success in clinical applications, including a short half-life, poor targeting property, low concentration at the target site, rapid clearance from the lesion region, and inefficient payload. In this review, we highlight exosome trafficking and cellular uptake and survey the latest discoveries in the context of exosome research as the best fit for brain targeting owing to its natural brain-homing abilities. Furthermore, we overview the methods by which researchers have bioengineered exosomes (BioEng-Exo) for stroke therapy. Finally, we summarize studies in which exosomes were bioengineered by a third party for stroke recovery. This review provides up-to-date knowledge about the versatile nature of exosomes with a special focus on BioEng-Exo for ischemic stroke. Standard exosome bioengineering techniques are mandatory for the future and will lead exosomes toward clinical success for stroke therapy.

cell biology,developmental biology
Engineered exosomes derived from stem cells: a new brain-targeted strategy

Waqas Ahmed,Songze Huang,Lukui Chen

DOI: https://doi.org/10.1080/17425247.2024.2306877

2024-01-26

Expert Opinion on Drug Delivery

Abstract:Introduction Using engineered exosomes produced from stem cells is an experimental therapeutic approach for treating brain diseases. According to reports, preclinical research has demonstrated notable neurogenesis and angiogenesis effects using modified stem cell-derived exosomes. These biological nanoparticles have a variety of anti-apoptotic, anti-inflammatory, and antioxidant properties that make them very promising for treating nervous system disorders.

pharmacology & pharmacy
Exosomes as a Nanodelivery System: a Key to the Future of Neuromedicine?

Arian Aryani,Bernd Denecke

DOI: https://doi.org/10.1007/s12035-014-9054-5

IF: 5.682

2014-12-15

Molecular Neurobiology

Abstract:Since the beginning of the last decade, exosomes have been of increased interest in the science community. Exosomes represent a new kind of long distance transfer of biological molecules among cells. This review provides a comprehensive overview about the construction of exosomes, their targeting and their fusion mechanisms to the recipient cells. Complementarily, the current state of research regarding the cargo of exosomes is discussed. A particular focus was placed on the role of exosomes in the central nervous system. An increasing number of physiological processes in the brain could be associated with exosomes. In this context, it is becoming more apparent that exosomes are involved in several neurological and specifically neurodegenerative diseases. The treatment of these kinds of diseases is often difficult not least because of the blood-brain barrier. Exosomes are very stable, can pass the blood-brain barrier and, therefore, reveal bright perspectives towards diagnosis and therapeutic treatments. A prerequisite for clinical applications is a standardised approach. Features necessary for a standardised diagnosis using exosomes are discussed. In therapeutic terms, exosomes represent a promising drug delivery system able to pass the blood-brain barrier. One option to overcome the disadvantages potentially associated with the use of endogenous exosomes is the design of artificial exosomes. The artificial exosomes with a clearly defined therapeutic active cargo and surface marker ensuring the specific targeting to the recipient cells is proposed as a promising approach.

neurosciences
Exosomes: A Cellular Communication Medium That Has Multiple Effects On Brain Diseases

Xiaoling Fang,Dishu Zhou,Xinyue Wang,Yujie Ma,Guangcheng Zhong,Shangwen Jing,Shuiqing Huang,Qi Wang

DOI: https://doi.org/10.1007/s12035-024-03957-4

IF: 5.682

2024-02-15

Molecular Neurobiology

Abstract:Exosomes, as membranous vesicles generated by multiple cell types and secreted to extracellular space, play a crucial role in a range of brain injury–related brain disorders by transporting diverse proteins, RNA, DNA fragments, and other functional substances. The nervous system's pathogenic mechanisms are complicated, involving pathological processes like as inflammation, apoptosis, oxidative stress, and autophagy, all of which result in blood-brain barrier damage, cognitive impairment, and even loss of normal motor function. Exosomes have been linked to the incidence and progression of brain disorders in recent research. As a result, a thorough knowledge of the interaction between exosomes and brain diseases may lead to the development of more effective therapeutic techniques that may be implemented in the clinic. The potential role of exosomes in brain diseases and the crosstalk between exosomes and other pathogenic processes were discussed in this paper. Simultaneously, we noted the delicate events in which exosomes as a media allow the brain to communicate with other tissues and organs in physiology and disease, and compiled a list of natural compounds that modulate exosomes, in order to further improve our understanding of exosomes and propose new ideas for treating brain disorders.

neurosciences
Cell-derived nanovesicle-mediated drug delivery to the brain: Principles and strategies for vesicle engineering

Yujie Liang,Zoya Iqbal,Jianping Lu,Jianhong Wang,Hao Zhang,Xi Chen,Li Duan,Jiang Xia

DOI: https://doi.org/10.1016/j.ymthe.2022.10.008

IF: 12.91

2022-10-01

Molecular Therapy

Abstract:Developing strategies toward safe and effective drug delivery into the central nervous system (CNS) with improved targeting abilities and reduced off-target effects is crucial. CNS-targeted drug carriers made of synthetic molecules raise concerns about their biodegradation, clearance, immune responses, and neurotoxicity. Cell-derived nanovesicles (CDNs) have recently been applied in CNS-targeted drug delivery, because of their intrinsic stability, biocompatibility, inherent homing capability, and the ability to penetrate through biological barriers, including the blood-brain barrier. Among these CDNs, extracellular vesicles and exosomes are the most studied because their surface can be engineered and modified to cater to brain targeting. In this review, we focus on the application of CDNs in brain-targeted drug delivery to treat neurological diseases. We cover recently developed methods of exosome derivation and engineering, including exosome-like particles, hybrid exosomes, exosome-associated adeno-associated viruses, and envelope protein nanocages. Finally, we discuss the limitations and project the future development of the CDN-based brain-targeted delivery systems, and conclude that engineered CDNs hold great potential in the treatment of neurological diseases.

genetics & heredity,medicine, research & experimental,biotechnology & applied microbiology
Navigating the brain: the role of exosomal shuttles in precision therapeutics

Shaheera Fatima,Ariba Qaiser,Saadia Andleeb,Asraf Hussain Hashmi,Sobia Manzoor

DOI: https://doi.org/10.3389/fneur.2023.1324216

IF: 3.4

2024-01-19

Frontiers in Neurology

Abstract:Brain diseases have become one of the leading roots of mortality and disability worldwide, contributing a significant part of the disease burden on healthcare systems. The blood-brain barrier (BBB) is a primary physical and biological obstacle that allows only small molecules to pass through it. Its selective permeability is a significant challenge in delivering therapeutics into the brain for treating brain dysfunction. It is estimated that only 2% of the new central nervous system (CNS) therapeutic compounds can cross the BBB and achieve their therapeutic targets. Scientists are exploring various approaches to develop effective cargo delivery vehicles to promote better therapeutics targeting the brain with minimal off-target side effects. Despite different synthetic carriers, one of the natural brain cargo delivery systems, "exosomes," are now employed to transport drugs through the BBB. Exosomes are naturally occurring small extracellular vesicles (EVs) with unique advantages as a therapeutic delivery system for treating brain disorders. They have beneficial innate aspects of biocompatibility, higher stability, ability to cross BBB, low cytotoxicity, low immunogenicity, homing potential, targeted delivery, and reducing off-site target effects. In this review, we will discuss the limitations of synthetic carriers and the utilization of naturally occurring exosomes as brain-targeted cargo delivery vehicles and highlight the methods for modifying exosome surfaces and drug loading into exosomes. We will also enlist neurodegenerative disorders targeted with genetically modified exosomes for their treatment.

neurosciences,clinical neurology
Strategies for Targeted Delivery of Exosomes to the Brain: Advantages and Challenges

Hojun Choi,Kyungsun Choi,Dae-Hwan Kim,Byung-Koo Oh,Hwayoung Yim,Soojin Jo,Chulhee Choi

DOI: https://doi.org/10.3390/pharmaceutics14030672

IF: 6.525

2022-03-18

Pharmaceutics

Abstract:Delivering therapeutics to the central nervous system (CNS) is difficult because of the blood-brain barrier (BBB). Therapeutic delivery across the tight junctions of the BBB can be achieved through various endogenous transportation mechanisms. Receptor-mediated transcytosis (RMT) is one of the most widely investigated and used methods. Drugs can hijack RMT by expressing specific ligands that bind to receptors mediating transcytosis, such as the transferrin receptor (TfR), low-density lipoprotein receptor (LDLR), and insulin receptor (INSR). Cell-penetrating peptides and viral components originating from neurotropic viruses can also be utilized for the efficient BBB crossing of therapeutics. Exosomes, or small extracellular vesicles, have gained attention as natural nanoparticles for treating CNS diseases, owing to their potential for natural BBB crossing and broad surface engineering capability. RMT-mediated transport of exosomes expressing ligands such as LDLR-targeting apolipoprotein B has shown promising results. Although surface-modified exosomes possessing brain targetability have shown enhanced CNS delivery in preclinical studies, the successful development of clinically approved exosome therapeutics for CNS diseases requires the establishment of quantitative and qualitative methods for monitoring exosomal delivery to the brain parenchyma in vivo as well as elucidation of the mechanisms underlying the BBB crossing of surface-modified exosomes.
Exosome-based drug delivery systems for enhanced neurological therapeutics

Safa A Vahab,Vyshma K V,Vrinda S Kumar

DOI: https://doi.org/10.1007/s13346-024-01710-x

2024-09-27

Drug Delivery and Translational Research

Abstract:Exosomes are small extracellular vesicles naturally secreted by cells into body fluids, enriched with bioactive molecules such as RNAs, proteins, and lipids. These nanosized vesicles play a crucial role in physiological and pathological processes by facilitating intercellular communication and modulating cellular responses, particularly within the central nervous system (CNS). Their ability to cross the blood–brain barrier and reflect the characteristics of their parent cells makes exosomal cargo a promising candidate for biomarkers in the early diagnosis and clinical assessment of neurological conditions. This review offers a comprehensive overview of current knowledge on the characterization of mammalian-derived exosomes, their application as drug delivery systems for neurological disorders, and ongoing clinical trials involving exosome-loaded cargo. Despite their promising attributes, a significant challenge remains the lack of standardized isolation methods, as current techniques are often complex, costly, and require sophisticated equipment, affecting the scalability and affordability of exosome-based therapies. The review highlights the engineering potential of exosomes, emphasizing their ability to be customized for targeted therapeutic delivery through surface modification or conjugation. Future advancements in addressing these challenges and leveraging the unique properties of exosomes could lead to innovative and effective therapeutic strategies in neurology.

pharmacology & pharmacy,medicine, research & experimental
Engineering exosomes for targeted drug delivery

Yujie Liang,Li Duan,Jianping Lu,Jiang Xia

DOI: https://doi.org/10.7150/thno.52570

IF: 11.6

2021-01-01

Theranostics

Abstract:Exosomes are cell-derived nanovesicles that are involved in the intercellular transportation of materials. Therapeutics, such as small molecules or nucleic acid drugs, can be incorporated into exosomes and then delivered to specific types of cells or tissues to realize targeted drug delivery. Targeted delivery increases the local concentration of therapeutics and minimizes side effects. Here, we present a detailed review of exosomes engineering through genetic and chemical methods for targeted drug delivery. Although still in its infancy, exosome-mediated drug delivery boasts low toxicity, low immunogenicity, and high engineerability, and holds promise for cell-free therapies for a wide range of diseases.

medicine, research & experimental
Exosomes as therapeutic and drug delivery vehicle for neurodegenerative diseases

Zeinab Nouri,Ashkan Barfar,Sahra Perseh,Hamidreza Motasadizadeh,Samane Maghsoudian,Yousef Fatahi,Keyvan Nouri,Mohaddese Pourashory Yektakasmaei,Rassoul Dinarvand,Fatemeh Atyabi

DOI: https://doi.org/10.1186/s12951-024-02681-4

2024-08-02

Abstract:Neurodegenerative disorders are complex, progressive, and life-threatening. They cause mortality and disability for millions of people worldwide. Appropriate treatment for neurodegenerative diseases (NDs) is still clinically lacking due to the presence of the blood-brain barrier (BBB). Developing an effective transport system that can cross the BBB and enhance the therapeutic effect of neuroprotective agents has been a major challenge for NDs. Exosomes are endogenous nano-sized vesicles that naturally carry biomolecular cargoes. Many studies have indicated that exosome content, particularly microRNAs (miRNAs), possess biological activities by targeting several signaling pathways involved in apoptosis, inflammation, autophagy, and oxidative stress. Exosome content can influence cellular function in healthy or pathological ways. Furthermore, since exosomes reflect the features of the parental cells, their cargoes offer opportunities for early diagnosis and therapeutic intervention of diseases. Exosomes have unique characteristics that make them ideal for delivering drugs directly to the brain. These characteristics include the ability to pass through the BBB, biocompatibility, stability, and innate targeting properties. This review emphasizes the role of exosomes in alleviating NDs and discusses the associated signaling pathways and molecular mechanisms. Furthermore, the unique biological features of exosomes, making them a promising natural transporter for delivering various medications to the brain to combat several NDs, are also discussed.
Engineering strategies and optimized delivery of exosomes for theranostic application in nerve tissue

Qicheng Li,Xiaoyang Fu,Yuhui Kou,Na Han

DOI: https://doi.org/10.7150/thno.84971

IF: 11.6

2023-07-24

Theranostics

Abstract:Severe injuries or diseases affecting the peripheral and central nervous systems can result in impaired organ function and permanent paralysis. Conventional interventions, such as drug administration and cell-based therapy, exhibit limited effectiveness due to their inability to preserve post-implantation cell survival and impede the deterioration of adjacent tissues. Exosomes have recently emerged as powerful tools for tissue repair owing to their proteins and nucleic acids, as well as their unique phospholipid properties, which facilitate targeted delivery to recipient cells. Engineering exosomes, obtained by manipulating the parental cells or directly functionalizing exosomes, play critical roles in enhancing regenerative repair, reducing inflammation, and maintaining physiological homeostasis. Furthermore, exosomes have been shown to restore neurological function when used in combination with biomaterials. This paper primarily focuses on the engineering strategies and delivery routes of exosomes related to neural research and emphasizes the theranostic application of optimized exosomes in peripheral nerve, traumatic spinal cord, and brain injuries. Finally, the prospects of exosomes development and their combination with other approaches will be discussed to enhance our knowledge on their theranostic effectiveness in neurological diseases.
The promise of exosome applications in treating central nervous system diseases

Jared Mattingly,Yuchen Li,Ji C. Bihl,Jinju Wang,Jared Mattingly,Yuchen Li,Ji C. Bihl,Jinju Wang

DOI: https://doi.org/10.1111/cns.13743

2021-10-12

Abstract:Exosomes (EXs), a type of extracellular vesicles, are secreted from virtually all types of cells. EXs serve as cell-to-cell communicators by conveying proteins and nucleic acids with regulatory functions. Increasing evidence shows that EXs are implicated in the pathogenesis of central nervous system (CNS) diseases. Moreover, EXs have recently been highlighted as a new promising therapeutic strategy for in vivo delivery of nucleotides and drugs. Studies have revealed that infusion of EXs elicits beneficial effects on the CNS injury animal models. As compared to cell-based therapy, EXs-based therapy for CNS diseases has unique advantages, opening a new path for neurological medicine. In this review, we summarized the current state of knowledge of EXs, the roles and applications of EXs as a viable pathological biomarker, and EX-based therapy for CNS diseases.

pharmacology & pharmacy,neurosciences
Engineered Extracellular Vesicles for Drug Delivery in Therapy of Stroke

Waqas Ahmed,Muhammed Shibil Kuniyan,Aqil Mohammad Jawed,Lukui Chen

DOI: https://doi.org/10.3390/pharmaceutics15092173

IF: 6.525

2023-08-22

Pharmaceutics

Abstract:Extracellular vesicles (EVs) are promising therapeutic modalities for treating neurological conditions. EVs facilitate intercellular communication among brain cells under normal and abnormal physiological conditions. The potential capability of EVs to pass through the blood–brain barrier (BBB) makes them highly promising as nanocarrier contenders for managing stroke. EVs possess several potential advantages compared to existing drug-delivery vehicles. These advantages include their capacity to surpass natural barriers, target specific cells, and stability within the circulatory system. This review explores the trafficking and cellular uptake of EVs and evaluates recent findings in the field of EVs research. Additionally, an overview is provided of the techniques researchers utilize to bioengineer EVs for stroke therapy, new results on EV–BBB interactions, and the limitations and prospects of clinically using EVs for brain therapies. The primary objective of this study is to provide a comprehensive analysis of the advantages and challenges related to engineered EVs drug delivery, specifically focusing on their application in the treatment of stroke.

pharmacology & pharmacy
Lactate dehydrogenase isoenzymes in prostate and testis of wild animals and some histological remarks.

K. van Camp,M. van Sande

DOI: https://doi.org/10.1007/bf00256045

Urological Research

Abstract:
Engineered exosomes enriched with select microRNAs amplify their therapeutic efficacy for traumatic brain injury and stroke

Liang Chen,Ye Xiong,Michael Chopp,Yanlu Zhang

DOI: https://doi.org/10.3389/fncel.2024.1376601

2024-03-19

Frontiers in Cellular Neuroscience

Abstract:Traumatic brain injury (TBI) and stroke stand as prominent causes of global disability and mortality. Treatment strategies for stroke and TBI are shifting from targeting neuroprotection toward cell-based neurorestorative strategy, aiming to augment endogenous brain remodeling, which holds considerable promise for the treatment of TBI and stroke. Compelling evidence underscores that the therapeutic effects of cell-based therapy are mediated by the active generation and release of exosomes from administered cells. Exosomes, endosomal derived and nano-sized extracellular vesicles, play a pivotal role in intercellular communication. Thus, we may independently employ exosomes to treat stroke and TBI. Systemic administration of mesenchymal stem cell (MSC) derived exosomes promotes neuroplasticity and neurological functional recovery in preclinical animal models of TBI and stroke. In this mini review, we describe the properties of exosomes and recent exosome-based therapies of TBI and stroke. It is noteworthy that the microRNA cargo within exosomes contributes to their therapeutic effects. Thus, we provide a brief introduction to microRNAs and insight into their key roles in mediating therapeutic effects. With the increasing knowledge of exosomes, researchers have "engineered" exosome microRNA content to amplify their therapeutic benefits. We therefore focus our discussion on the therapeutic benefits of recently employed microRNA-enriched engineered exosomes. We also discuss the current opportunities and challenges in translating exosome-based therapy to clinical applications.

neurosciences
Therapeutic and Diagnostic Potential of Exosomes as Drug Delivery Systems in Brain Cancer

Dimitrios I. Avgoulas,Konstantinos S. Tasioulis,Rigini M. Papi,Anastasia A. Pantazaki

DOI: https://doi.org/10.3390/pharmaceutics15051439

IF: 6.525

2023-05-09

Pharmaceutics

Abstract:Cancer is designated as one of the principal causes of mortality universally. Among different types of cancer, brain cancer remains the most challenging one due to its aggressiveness, the ineffective permeation ability of drugs through the blood–brain barrier (BBB), and drug resistance. To overcome the aforementioned issues in fighting brain cancer, there is an imperative need for designing novel therapeutic approaches. Exosomes have been proposed as prospective "Trojan horse" nanocarriers of anticancer theranostics owing to their biocompatibility, increased stability, permeability, negligible immunogenicity, prolonged circulation time, and high loading capacity. This review provides a comprehensive discussion on the biological properties, physicochemical characteristics, isolation methods, biogenesis and internalization of exosomes, while it emphasizes their therapeutic and diagnostic potential as drug vehicle systems in brain cancer, highlighting recent advances in the research field. A comparison of the biological activity and therapeutic effectiveness of several exosome-encapsulated cargo including drugs and biomacromolecules underlines their great supremacy over the non-exosomal encapsulated cargo in the delivery, accumulation, and biological potency. Various studies on cell lines and animals give prominence to exosome-based nanoparticles (NPs) as a promising and alternative approach in the management of brain cancer.

pharmacology & pharmacy
Diagnostic and Therapeutic Potential of Exosomes in Neurodegenerative Diseases

Panyue Gao,Xinrong Li,Xinzhe Du,Sha Liu,Yong Xu

DOI: https://doi.org/10.3389/fnagi.2021.790863

IF: 4.8

2021-12-16

Frontiers in Aging Neuroscience

Abstract:Neurodegenerative diseases are closely related to brain function and the progression of the diseases are irreversible. Due to brain tissue being not easy to acquire, the study of the pathophysiology of neurodegenerative disorders has many limitations—lack of reliable early biomarkers and personalized treatment. At the same time, the blood-brain barrier (BBB) limits most of the drug molecules into the damaged areas of the brain, which makes a big drop in the effect of drug treatment. Exosomes, a kind of endogenous nanoscale vesicles, play a key role in cell signaling through the transmission of genetic information and proteins between cells. Because of the ability to cross the BBB, exosomes are expected to link peripheral changes to central nervous system (CNS) events as potential biomarkers, and can even be used as a therapeutic carrier to deliver molecules specifically to CNS. Here we summarize the role of exosomes in pathophysiology, diagnosis, prognosis, and treatment of some neurodegenerative diseases (Alzheimer’s Disease, Parkinson’s Disease, Huntington’s Disease, Amyotrophic Lateral Sclerosis).

neurosciences,geriatrics & gerontology,gerontology
Engineering exosomes as refined biological nanoplatforms for drug delivery

Xin Luan,Kanokwan Sansanaphongpricha,Ila Myers,Hongwei Chen,Hebao Yuan,Duxin Sun

DOI: https://doi.org/10.1038/aps.2017.12

IF: 7.169

2017-04-10

Acta Pharmacologica Sinica

Abstract:Exosomes, a subgroup of extracellular vesicles (EVs), have been recognized as important mediators of long distance intercellular communication and are involved in a diverse range of biological processes. Because of their ideal native structure and characteristics, exosomes are promising nanocarriers for clinical use. Exosomes are engineered at the cellular level under natural conditions, but successful exosome modification requires further exploration. The focus of this paper is to summarize passive and active loading approaches, as well as specific exosome modifications and examples of the delivery of therapeutic and imaging molecules. Examples of exosomes derived from a variety of biological origins are also provided. The biocompatible characteristics of exosomes, with suitable modifications, can increase the stability and efficacy of imaging probes and therapeutics while enhancing cellular uptake. Challenges in clinical translation of exosome-based platforms from different cell sources and the advantages of each are also reviewed and discussed.

pharmacology & pharmacy,chemistry, multidisciplinary

Combined effects of cafeteria and tube-feeding on energy balance in the rat.

Engineered exosomes: desirable target-tracking characteristics for cerebrovascular and neurodegenerative disease therapies

Native and Bioengineered Exosomes for Ischemic Stroke Therapy

Engineered exosomes derived from stem cells: a new brain-targeted strategy

Exosomes as a Nanodelivery System: a Key to the Future of Neuromedicine?

Exosomes: A Cellular Communication Medium That Has Multiple Effects On Brain Diseases

Cell-derived nanovesicle-mediated drug delivery to the brain: Principles and strategies for vesicle engineering

Navigating the brain: the role of exosomal shuttles in precision therapeutics

Strategies for Targeted Delivery of Exosomes to the Brain: Advantages and Challenges

Exosome-based drug delivery systems for enhanced neurological therapeutics

Engineering exosomes for targeted drug delivery

Exosomes as therapeutic and drug delivery vehicle for neurodegenerative diseases

Engineering strategies and optimized delivery of exosomes for theranostic application in nerve tissue

The promise of exosome applications in treating central nervous system diseases

Engineered Extracellular Vesicles for Drug Delivery in Therapy of Stroke

Lactate dehydrogenase isoenzymes in prostate and testis of wild animals and some histological remarks.

Engineered exosomes enriched with select microRNAs amplify their therapeutic efficacy for traumatic brain injury and stroke

Therapeutic and Diagnostic Potential of Exosomes as Drug Delivery Systems in Brain Cancer

Diagnostic and Therapeutic Potential of Exosomes in Neurodegenerative Diseases

Engineering exosomes as refined biological nanoplatforms for drug delivery